JP2025138641A5 - - Google Patents
Info
- Publication number
- JP2025138641A5 JP2025138641A5 JP2025088861A JP2025088861A JP2025138641A5 JP 2025138641 A5 JP2025138641 A5 JP 2025138641A5 JP 2025088861 A JP2025088861 A JP 2025088861A JP 2025088861 A JP2025088861 A JP 2025088861A JP 2025138641 A5 JP2025138641 A5 JP 2025138641A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962898249P | 2019-09-10 | 2019-09-10 | |
| US62/898,249 | 2019-09-10 | ||
| US201962931608P | 2019-11-06 | 2019-11-06 | |
| US62/931,608 | 2019-11-06 | ||
| PCT/US2020/050206 WO2021050732A1 (en) | 2019-09-10 | 2020-09-10 | Methods of treating kras mutant cancers |
| JP2022515487A JP2022547167A (ja) | 2019-09-10 | 2020-09-10 | Ｋｒａｓ変異型がんを治療する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515487A Division JP2022547167A (ja) | 2019-09-10 | 2020-09-10 | Ｋｒａｓ変異型がんを治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025138641A JP2025138641A (ja) | 2025-09-25 |
| JP2025138641A5 true JP2025138641A5 (enExample) | 2026-01-22 |
Family
ID=74866476
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515487A Pending JP2022547167A (ja) | 2019-09-10 | 2020-09-10 | Ｋｒａｓ変異型がんを治療する方法 |
| JP2025088861A Pending JP2025138641A (ja) | 2019-09-10 | 2025-05-28 | Ｋｒａｓ変異型がんを治療する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515487A Pending JP2022547167A (ja) | 2019-09-10 | 2020-09-10 | Ｋｒａｓ変異型がんを治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220331401A1 (enExample) |
| EP (1) | EP4028044A4 (enExample) |
| JP (2) | JP2022547167A (enExample) |
| KR (1) | KR20220061997A (enExample) |
| CN (1) | CN114375197A (enExample) |
| AU (1) | AU2020346820B2 (enExample) |
| CA (1) | CA3149872A1 (enExample) |
| WO (1) | WO2021050732A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019217307A1 (en) | 2018-05-07 | 2019-11-14 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| AU2019338207B2 (en) | 2018-09-10 | 2025-01-02 | Mirati Therapeutics, Inc. | Combination therapies |
| CA3112043A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| US12208099B2 (en) | 2018-09-10 | 2025-01-28 | Mirati Therapeutics, Inc. | Combination therapies |
| SMT202500028T1 (it) | 2018-09-10 | 2025-03-12 | Mirati Therapeutics Inc | Terapie combinate |
| US12377101B2 (en) | 2018-12-05 | 2025-08-05 | Mirati Therapeutics, Inc. | Combination therapies |
| WO2020146613A1 (en) | 2019-01-10 | 2020-07-16 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| CN114615981B (zh) | 2019-08-29 | 2024-04-12 | 米拉蒂治疗股份有限公司 | Kras g12d抑制剂 |
| CN114761012B (zh) | 2019-09-24 | 2025-03-21 | 米拉蒂治疗股份有限公司 | 组合疗法 |
| PH12022551513A1 (en) | 2019-12-20 | 2023-04-24 | Mirati Therapeutics Inc | Sos1 inhibitors |
| US12655160B2 (en) | 2020-08-04 | 2026-06-16 | Mirati Therapeutics, Inc. | KRAS G12D inhibitors |
| EP4210833A4 (en) | 2020-09-11 | 2024-09-11 | Mirati Therapeutics, Inc. | CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR |
| EP4216951B1 (en) | 2020-09-22 | 2026-04-01 | Mirati Therapeutics, Inc. | Kras g12d inhibitors |
| EP4262807A4 (en) | 2020-12-15 | 2025-04-23 | Mirati Therapeutics, Inc. | Azachinazoline pan-KRAS inhibitors |
| WO2022133038A1 (en) | 2020-12-16 | 2022-06-23 | Mirati Therapeutics, Inc. | Tetrahydropyridopyrimidine pan-kras inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118141922A (zh) * | 2016-12-06 | 2024-06-07 | 小利兰·斯坦福大学理事会 | 睫状神经营养因子受体配体结合剂及其使用方法 |
| WO2018128745A1 (en) * | 2017-01-06 | 2018-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Ciliary neurotrophic factor receptor ligands and methods of using the same |
-
2020
- 2020-09-10 US US17/639,525 patent/US20220331401A1/en active Pending
- 2020-09-10 EP EP20863554.0A patent/EP4028044A4/en active Pending
- 2020-09-10 CN CN202080063707.0A patent/CN114375197A/zh active Pending
- 2020-09-10 KR KR1020227010002A patent/KR20220061997A/ko active Pending
- 2020-09-10 AU AU2020346820A patent/AU2020346820B2/en active Active
- 2020-09-10 JP JP2022515487A patent/JP2022547167A/ja active Pending
- 2020-09-10 CA CA3149872A patent/CA3149872A1/en active Pending
- 2020-09-10 WO PCT/US2020/050206 patent/WO2021050732A1/en not_active Ceased
-
2025
- 2025-05-28 JP JP2025088861A patent/JP2025138641A/ja active Pending